Literature DB >> 12231453

Stress-induced mitochondrial depolarization and oxidative damage in PSP cybrids.

Jason W Chirichigno1, Giovanni Manfredi, M Flint Beal, David S Albers.   

Abstract

Increased oxidative damage and mitochondrial dysfunction have been suggested to play critical roles in the pathogenesis of progressive supranuclear palsy (PSP) yet the specific intracellular defects which cause and can result from these oxidative and bioenergetic defects remain unclear. To extend our previous PSP cybrid findings, we measured electron transport chain (ETC) activities in cell lines expressing mitochondrial genes from patients with PSP. Further, we measured changes in mitochondrial membrane potential as well as lipid peroxidation in PSP and control cybrids in response to mitochondrial toxins. We observed significant decreases in complex I+III activity in PSP cybrids as well as significant increases in markers of lipid oxidative damage as compared to control cybrids. These results coupled with previous reports from this and other laboratories strongly suggest contributory roles of mitochondrial dysfunction and oxidative damage in PSP, possibly due to genetic abnormalities and/or damage of mitochondrial DNA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12231453     DOI: 10.1016/s0006-8993(02)03101-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  Mitochondrial dysfunction as a therapeutic target in progressive supranuclear palsy.

Authors:  Vincent Ries; Wolfgang H Oertel; Günter U Höglinger
Journal:  J Mol Neurosci       Date:  2011-07-27       Impact factor: 3.444

Review 2.  Clinical trials: past, current, and future for atypical Parkinsonian syndromes.

Authors:  Richard M Tsai; Adam L Boxer
Journal:  Semin Neurol       Date:  2014-06-25       Impact factor: 3.420

Review 3.  Mitochondrial medicine for neurodegenerative diseases.

Authors:  Heng Du; Shirley ShiDu Yan
Journal:  Int J Biochem Cell Biol       Date:  2010-01-11       Impact factor: 5.085

Review 4.  Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies.

Authors:  Heather M Wilkins; Steven M Carl; Russell H Swerdlow
Journal:  Redox Biol       Date:  2014-04-01       Impact factor: 11.799

5.  Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation.

Authors:  Plamena R Angelova; Mario Barilani; Christopher Lovejoy; Marta Dossena; Mariele Viganò; Agostino Seresini; Daniela Piga; Sonia Gandhi; Gianni Pezzoli; Andrey Y Abramov; Lorenza Lazzari
Journal:  Redox Biol       Date:  2017-10-20       Impact factor: 11.799

6.  Segregation and potential functional impact of a rare stop-gain PABPC4L variant in familial atypical Parkinsonism.

Authors:  Muhammad Aslam; Anwar Ullah; Nagarajan Paramasivam; Nirosiya Kandasamy; Saima Naureen; Mazhar Badshah; Kafaitullah Khan; Muhammad Wajid; Rashda Abbasi; Roland Eils; Marc A Brockmann; Matthias Schlesner; Nafees Ahmad; Jakob von Engelhardt
Journal:  Sci Rep       Date:  2019-09-19       Impact factor: 4.379

7.  NIX-Mediated Mitophagy Promotes Effector Memory Formation in Antigen-Specific CD8+ T Cells.

Authors:  Shubhranshu S Gupta; Robert Sharp; Colby Hofferek; Le Kuai; Gerald W Dorn; Jin Wang; Min Chen
Journal:  Cell Rep       Date:  2019-11-12       Impact factor: 9.423

Review 8.  Understanding the Multiple Role of Mitochondria in Parkinson's Disease and Related Disorders: Lesson From Genetics and Protein-Interaction Network.

Authors:  Valentina Nicoletti; Giovanni Palermo; Eleonora Del Prete; Michelangelo Mancuso; Roberto Ceravolo
Journal:  Front Cell Dev Biol       Date:  2021-04-01

9.  CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial.

Authors:  Diana Apetauerova; Stephanie A Scala; Robert W Hamill; David K Simon; Subash Pathak; Robin Ruthazer; David G Standaert; Talene A Yacoubian
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-08-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.